700 Industrial Park Drive
Alabaster, AL 35007
1-800-227-0651 or 205-663-2494
Fax 1-800-229-1004 or 205-663-0756
Orders:
Technical Questions:

General Information:
"); // global background

Synthetic Products

Sphingolipids
Ceramides - made from D-erythro-sphingosine
Purity > 99%
Ceramide C2:0

MW
Catalog Number
 
341.53
860502
Product Data

Ceramide C4:0
MW
Catalog Number
 
369.59
860504
Product Data

Ceramide C6:0
MW
Catalog Number
 
397.64
860506
Product Data

Ceramide C8:0
MW
Catalog Number
 
425.70
860508
Product Data

Ceramide C10:0
MW
Catalog Number
 
453.75
860510
Product Data

Ceramide C12:0
MW
Catalog Number
 
481.80
860512
Product Data

Ceramide C14:0
MW
Catalog Number
 
509.86
860514
Product Data

Ceramide C16:0
MW
Catalog Number
 
537.91
860516
Product Data

Ceramide C17:0
MW
Catalog Number
 
551.94
860517
Product Data

Ceramide C18:0
MW
Catalog Number
 
565.96
860518
Product Data

Ceramide C18:1
MW
Catalog Number
 
563.95
860519
Product Data

Ceramide C20:0
MW
Catalog Number
 
594.02
860520
Product Data

Ceramide C24:0
MW
Catalog Number
 
650.13
860524
Product Data

Ceramide C24:1
MW
Catalog Number
 
648.11
860525
Product Data

References:
  1. Mengubas K; Riordan FA; Bravery CA; Lewin J; Owens DL; Mehta AB; Hoffbrand AV; Wickremasinghe RG; (1999), Ceramideinduced killing of normal and malignant human lymphocytes is by a nonapoptotic mechanism. Oncogene, 18:15, 2499506

  2. Hanna AN; Chan EY; Xu J; Stone JC; Brindley DN; (1999), A novel pathway for tumor necrosis factoralpha and ceramide signaling involving sequential activation of tyrosine kinase, p21(ras), and phosphatidylinositol 3kinase. J Biol Chem, 274:18, 127229
© Avanti Polar Lipids, Inc. All rights reserved. Terms of Use | Privacy Policy | Comments